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ARTICLE
Helminth-induced IL-4 expands bystander memory
CD8+ T cells for early control of viral infection
Marion Rolot1, Annette M. Dougall1, Alisha Chetty2, Justine Javaux1, Ting Chen1, Xue Xiao1, Bénédicte Machiels1,
Murray E. Selkirk 3, Rick M. Maizels4, Cornelis Hokke 5, Olivier Denis6, Frank Brombacher2,7,8,
Alain Vanderplasschen1, Laurent Gillet1, William G. C. Horsnell2,9,10 & Benjamin G. Dewals1
Infection with parasitic helminths can imprint the immune system to modulate bystander
inﬂammatory processes. Bystander or virtual memory CD8+ T cells (TVM) are non-
conventional T cells displaying memory properties that can be generated through respon-
siveness to interleukin (IL)-4. However, it is not clear if helminth-induced type 2 immunity
functionally affects the TVM compartment. Here, we show that helminths expand
CD44hiCD62LhiCXCR3hiCD49dlo TVM cells through direct IL-4 signaling in CD8+ T cells.
Importantly, helminth-mediated conditioning of TVM cells provided enhanced control of acute
respiratory infection with the murid gammaherpesvirus 4 (MuHV-4). This enhanced control
of MuHV-4 infection could further be explained by an increase in antigen-speciﬁc CD8+ T
cell effector responses in the lung and was directly dependent on IL-4 signaling. These results
demonstrate that IL-4 during helminth infection can non-speciﬁcally condition CD8+ T cells,
leading to a subsequently raised antigen-speciﬁc CD8+ T cell activation that enhances
control of viral infection.
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Soil-transmitted helminths and schistosomes infect morethan a quarter of the world population, essentially afﬂictingpeople who live in areas of poverty in the developing
world1. Heavy parasite infections cause morbidity and mortality
that can occur at levels high enough to delay socio-economic
development2. Low-burden infections with helminths while
mostly asymptomatic can still have bystander effects on other
diseases, especially in the case of autoimmunity and allergy3,4,
thus advocating the use of speciﬁc helminths or derived
products as therapeutic strategies while encouraging guided
deworming campaigns5. However, how bystander helminth
infections modulate the control of heterologous pathogens such
as viruses is understood in only a limited number of contexts and
reports of both beneﬁcial and detrimental effects on viral
pathology exist6–10.
Memory establishment and maintenance is the hallmark of the
adaptive immune system and essential for ultimate control of
many pathogens. B and T lymphocytes are unique in their ability
to acquire immune memory against speciﬁc antigens (Ag) in
order to provide these high levels of protection. However, these
lymphocytes can also launch less stringent, but still effective
responses to either antigen or host immune responses11,12. Fur-
thermore, conditioning of T cells can impart memory-like
properties and functions in absence of encounter of their cog-
nate Ag13, and be important for priming CD4+ T cells for sub-
sequent type 2 immunity14. This is also the case for CD8+ T cells;
bystander or virtual memory CD8+ T cells (TVM) emerge from
early in life in naive mice15–18 and humans19,20 in the absence of
speciﬁc Ag stimulation and are thus Ag-inexperienced. TVM cells
have a memory-like phenotype with more effective responses to
Ag encounter compared to naïve cells and characterized by
expression of high levels of CD44 and also CD62L but low levels
of CD49d (α4 integrin). TVM emerge in naive mice with an
unrestricted TCR repertoire and in response to various stimuli
including IL-15, IFN-I, and IL-413,20–22. While TCR involvement
remains to be fully deciphered, recent data suggest that TVM are
favored by stronger TCR signals against self-antigens but main-
tain self-tolerance13,21–24. Whereas TVM development in C57BL/6
mice mostly depends on IL-15, IL-4 is the main driver of TVM
expansion in BALB/c mice25.
Parasitic helminths induce type 2 immunity characterized by
high levels of IL-426. Bystander consequences of this strong
induction of IL-4 on memory CD8+ T cells is not well under-
stood in the context of helminth infection that also drive strong
regulatory responses. In this study, we show that infection with
helminths (Schistosoma mansoni, Nippostongylus brasiliensis, and
Heligmosomoides polygyrus) or immunization with S. mansoni
Ags, expands bystander TVM cells in secondary lymphoid tissues
via IL-4. This Ag-nonspeciﬁc conditioning of CD8+ T cells prior
to encounter of their speciﬁc Ag provides early and enhanced
control of a subsequent gammaherpesvirus acute infection. This
enhanced protection was the result of higher levels of virus-
speciﬁc CD8+ T cell effector responses. Thus, during helminth
infection IL-4 can expand and condition TVM cells for more rapid
CD8 responses against subsequent cognate Ag encounter.
Results
S. mansoni eggs induce TVM in peripheral lymphoid tissues. To
investigate how the TVM cellular compartment is affected by
helminth-induced inﬂammation, we ﬁrst used a well-
characterized experimental model for inducing type 2 inﬂam-
mation by helminth Ags, in which eggs of the trematode parasite
S. mansoni are injected intraperitoneally (i.p.) to 6–8-week-old
female BALB/c mice before intravenous challenge (i.v.) 2 weeks
later, and responses measured at d22 after the ﬁrst injection
(Supplementary Figure 1a)27. We conﬁrmed that S. mansoni eggs
induced eosinophilic granulomas in the lung (Supplementary
Figure 1b) and typical type 2 inﬂammation with high levels of
soluble schistosome egg Ag (SEA)-speciﬁc IgG1 (Supplementary
Figure 1c) and IL-4 production upon SEA restimulation of the
dLN (Supplementary Figure 1d).
The CD8+ T cell populations were initially compared from
lung, dLN and spleen of BALB/c mice subjected to S. mansoni egg
immunization or not and according to their expression of CD44,
CD62L, and CD49d (Supplementary Figure 1b). S. mansoni-
driven type 2 inﬂammation did not induce signiﬁcant increase of
lung or spleen cellularity while cell numbers in the dLN were
increased (Fig. 1a). There was no overt response in the lung,
despite increased true memory CD44hiCD49dhi T cell (TTM)
proportions (Fig. 1b–d). However, responses in dLN and spleen
were signiﬁcantly affected with strikingly increased numbers and
proportions of CD44hiCD49dlo T cells, corresponding to the TVM
compartment. Increased levels of eomesodermin (Eomes) were
also found in TVM cells after S. mansoni egg immunization,
whereas TVM retained low-expression levels of T-bet (Fig. 1e, f), a
typical feature of TVM cells22.
IL-4 directs the expansion of TVM after helminth exposure. We
then investigated the implication of IL-4 responsiveness in the
expansion of the TVM pool after S. mansoni egg immunization.
We conﬁrmed that treatment with IL-4 complexes (IL-4c) strik-
ingly induced CD44hiCD49dlo TVM cells28 expressing high levels
of Eomes (Fig. 2a, b). IL-4 drives the expansion of TVM cells
expressing CXCR329. Thus, we further included CXCR3 surface
expression in our analyses and observed that the main part of
CD44hiCXCR3hi cells expressed high levels of CD62L and that
population expressed low levels of CD49d, corresponding to TVM
cells (Fig. 2c). The expansion of CXCR3hi TVM cells was further
observed after S. mansoni egg immunization restricted to i.p.
injection (Supplementary Figure 2a) or immunization with SEA
or the Th2-driving schistosome egg recombinant protein omega-1
(Supplementary Figure 2b). TVM expansion and Eomes upregu-
lation was also observed in mice at later time points after S.
mansoni egg immunization (d29 and d43 after initial i.p.), sug-
gesting that conditioning of TVM is long lasting (Supplementary
Figure 2c). Furthermore, we also observed TVM expansion during
other helminth-driven IL-4 dominated responses such as natural
infection with N. brasiliensis at day 10 pi (Supplementary Fig-
ure 2d), and a signiﬁcant TVM expansion and Eomes upregulation
could also be observed by day 35 pi (Supplementary Figure 2e). In
addition, natural infection with H. polygyrus at day 15 pi (Sup-
plementary Figure 2f, g), and S. mansoni at week 7 pi (Supple-
mentary Figure 2h) also caused increased TVM cell responses.
These results further indicated that IL-4-dominated responses to
helminth Ags can drive a long-lasting expansion of TVM cells in
peripheral lymphoid tissue.
S. mansoni egg injection to Il4ra−/− BALB/c mice did not
result in the expansion of TVM cells (Fig. 2d) and unbiased
restimulation of splenocytes with phorbol myristate acetate
(PMA) and ionomycin resulted in increased IFN-γ production
by CD8+ T cells that was dependent on IL-4 receptor expression
(Fig. 2e). We further sought to determine whether TVM expansion
was directly dependent upon IL-4 responsiveness of CD8+
T cells. Mixed chimeras were generated with congenically distinct
BM from WT or Il4ra−/− BALB/c mice and subjected to S.
mansoni egg immunization (Fig. 2f) or S. mansoni natural
infection (Supplementary Figure 2i). Similar chimerism was
observed in both S. mansoni egg- or phosphate-buffered saline
(PBS)-treated mice. As in the intact mice, the frequency of TVM
cells and Eomes expression levels in TVM cells were signiﬁcantly
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Fig. 1 S. mansoni eggs induce CD44hiCD49dlo CD8+ T cell expansion in the draining LN and spleen. BALB/c mice were injected with S. mansoni (Sm) eggs i.
p. and challenged i.v. (5000 per injection) at d14 before analysis at d22. a Absolute cell number at d22 in the indicated tissue. b Representative ﬂow
contour plots of gated CD8+ T cells of the indicated tissue at d22. Numbers indicate percent of events in each gate. c Cell number of CD44lo (naive T cells,
TN), CD44hiCD49dhi (true memory T cells, TTM) and CD44hiCD49dlo (virtual memory, TVM) CD8+ T cells as determined by ﬂow cytometric analysis. d
Percentage of CD44lo TN, CD44hiCD49dhi TTM and CD44hiCD49dlo TVM cells in CD8+ T cells as determined by ﬂow cytometric analysis. e Representative
histograms of PBS- or Sm egg-treated spleen CD8+ T cells. Gates were placed on CD44lo TN, CD44hiCD49dhi TTM and CD44hiCD49dlo TVM cells. Flow
histograms show respective expression of Eomes and T-bet. f Median ﬂuorescence intensities (MFI) of T-bet and Eomes at day 22 from the indicated
populations after Sm egg injection. Statistical signiﬁcance calculated using two-way analysis of variance (ANOVA) and Dunnett’s (PBS as reference mean)
or Sidak’s multiple-comparison test (**P < 0.01, ***P < 0.001, ****P < 0.0001). Data are representative of three independent experiments with 4 mice per
group (mean ± s.e.m. in a, c, d, f)
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Fig. 2 IL-4 signaling in CD8+ T cells expands TVM after S. mansoni egg immunization. a IL-4c treatment in BALB/c mice at d0 and d2 before analysis at d4.
Percentages of spleen naive T cells (TN, CD44lo), true memory (TTM, CD44hiCD49dhi) and virtual memory (TVM, CD44hiCD49dlo) CD8+ T cells. b
Intracellular Eomes in spleen TVM cells after IL-4c treatment as in (a). MFI median ﬂuorescence intensity. c BALB/c mice were injected with S. mansoni (Sm)
eggs i.p. and challenged i.v. (5000 per injection) at day 14 before analysis at day 22. Representative contour plots gated on spleen CD8+ T cells. Gates were
placed depending on CD44 and CXCR3 to deﬁne CD44loCXCR3lo TN, CD44hiCXCR3lo Tint, CD44hiCXCR3hiCD62LloCD49dhi TTM and
CD44hiCXCR3hiCD62LhiCD49dlo TVM cells. Histogram overlay shows respective CD49d expression in each population. d Percentages of spleen
CD44hiCXCR3hiCD62LhiCD49dlo TVM cells in WT and Il4ra−/− mice after Sm egg were injected i.p. and analysis performed at d7. e Percentage of IFN-γ
producing splenic CD8+ T cells from WT and Il4ra−/− following restimulation with PMA and ionomycin as determined by ﬂow cytometric analysis. fMixed
BM chimeras were generated by introducing WT CD45.1 and Il4ra−/− CD45.2 BALB/c donor BM into lethally irradiated WT CD45.1.2 BALB/c hosts. Eight
weeks later, chimeric mice were injected with Sm eggs. Representative contour plots are shown from a Sm egg-treated spleen. Percentage of chimerism,
CD44hiCD49dhi TTM, CXCR3hiCD49dlo TVM, and Eomes expression in TVM (MFI) for both donor populations in spleen are shown. g Tetramer-based
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***P < 0.001, ****P < 0.0001). Data are representative of two to three independent experiments with three to nine mice per group (mean ± s.e.m.)
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increased in the WT compartment after exposure to the parasite
(Fig. 2f and Supplementary Figure 2g). However, CXCR3hiCD49-
dlo TVM cells of the Il4ra−/− genotype were signiﬁcantly reduced
in naive mice compared to WT compartment and did not expand
after helminth exposure. These results demonstrated that IL-4
responsiveness of CD8+ T cells conditions and expands TVM cells
after S. mansoni egg immunization or natural infection.
Next, in order to examine whether IL-4-dependent TVM
expansion would not also result from an Ag-speciﬁc response to
S. mansoni eggs, a tetramer-based enrichment was performed on
an unrelated and randomly chosen population of CD8+ T cells
expressing a TCR speciﬁc to the H-2Kd-restricted SYVPSAEQI
peptide of the circumsporozoite protein (CSP280–288) of Plamo-
dium yoelii (Supplementary Figure 2j). We observed that
exposure to S. mansoni eggs also caused increased proportions
of CD44hiCXCR3hi CSP280–288-speciﬁc CD8+ T cells (Fig. 2g).
These results further support that expansion of TVM induced by
helminth exposure is Ag-nonspeciﬁc.
Helminths ameliorate the control of MuHV-4 infection. Ag-
inexperienced TVM cells respond more quickly to their cognate
Ag than naive T cells30 and IL-4 signaling in memory CD8+
T cells were previously suggested to reduce effector responses28.
Thus, we investigated whether expanding the TVM pool through
helminth exposure would affect effector CD8+ T cell responses
against heterologous Ags.
Murid herpesvirus 4 (MuHV-4) is a gammaherpesvirus that
infects the laboratory mouse and establishes long term persis-
tence31. Interestingly, levels of primary MuHV-4 lytic infection are
directly dependent on effective development of effector CD8+
T cells32. MuHV-4 was therefore used to assess virus-speciﬁc
CD8+ T cell responses after exposure to helminth Ags. We ﬁrst
immunized 8-week-old female BALB/c mice with S. mansoni eggs
before their infection with 1 × 104 plaque-forming units (PFU) of
MuHV-4 intranasally under general anesthesia (Fig. 3a). A control
group consisted of PBS-treated mice. Immunization with S.
mansoni eggs protected against transient weight loss caused by
MuHV-4 respiratory infection (Fig. 3b) and was associated with
reduced levels of infection at day 7 postviral infection (pvi) as
determined by immunostaining on lung tissue (Fig. 3c) and plaque
assay (Fig. 3e). We next measured the levels of infection over time
using MuHV-4-luc recombinant virus for live imaging of light
emission centered on the thorax at days 2, 5, 7, and 9 pvi33. S.
mansoni egg treatment resulted in signiﬁcantly reduced levels of
light emission by d7 pvi (Fig. 3d). There was a similar early control
of respiratory MuHV-4 infection when BALB/c mice were infected
49 days after percutaneous exposure to S. mansoni cercariae, a
time point corresponding to the peak of the response against the
parasite eggs (Supplementary Figure 3a), whereas enhanced
control of viral infection was not apparent when mice were
coinfected at earlier time points of the parasite life cycle. Likewise,
enhanced control of viral infection was also observed when mice
were infected with MuHV-4 at d6 or d35 after infection with N.
brasiliensis (Supplementary Figure 3b and c).
Colonization of the host by MuHV-4 after lytic respiratory
infection was not signiﬁcantly affected by prior exposure to S.
mansoni eggs as attested by live imaging of light emission
centered on the superﬁcial cervical LN (scLN, Fig. 3f) and qPCR
for viral genome detection in the spleen at days 5, 7, 11, and 20
pvi (Fig. 3g). These observations further supported a role of CD8-
dependent viral control during lytic replication as effective
MuHV-4-speciﬁc CD8+ T cell responses were shown to be
unable to control the establishment of viral latency34. We further
observed that increasing MuHV-4 infectious dose resulted in
enhanced control (Fig. 3h) and daily imaging of mice infected
with 1 × 104 PFU showed similar infection levels up to days 5–6
pvi before being controlled in S. mansoni-exposed mice (Fig. 3i),
suggesting enhanced adaptive immune responses rather than
impaired viral growth.
Helminths augment lung CD8+ T cell responses to MuHV-4.
We next assessed the immune response against MuHV-4 in
BALB/c mice that were exposed to S. mansoni eggs or not. We
observed no signiﬁcant difference in the antibody responses
against MuHV-4 (Supplementary Figure 4a) and global cellularity
in lungs at day 7 pvi was not affected (Supplementary Figure 4b).
Whereas eosinophils and DC numbers were signiﬁcantly
increased in mice exposed to S. mansoni eggs, numbers of neu-
trophils, macrophages, monocytes, B or CD4+ T cells were not
affected (Supplementary Figure 4b). Strikingly, the frequency and
number of lung CD8+ T cells was signiﬁcantly increased at day 7
pvi in mice immunized with S. mansoni eggs (Fig. 4a–c) and mice
infected percutaneously with S. mansoni cercariae 7 weeks before
MuHV-4 infection (Fig. 4d). Such enhanced CD8+ T cell
response was associated with increased proportions of
CD44hiCD62Llo effector T cells (Fig. 4e). We further observed
that effector CD44hiCD62LloCD49dhi CD8+ T cell responses
were transiently but signiﬁcantly increased by day 7 pvi in the
bronchoalveolar lavage ﬂuid (BALF) and lungs of mice prior
exposed to S. mansoni eggs (Fig. 4f), as well as short-lived effector
T cells (KLRG1+CD127−) (Fig. 4g). These results suggest that
prior exposure to helminths enhances CD8+ T cell responses
after MuHV-4 infection.
Enhanced virus-speciﬁc CD8 response after helminth exposure.
We further sought to evaluate the effector role of CD8+ T cell
responses against MuHV-4 infection in BALB/c mice after
exposure to S. mansoni eggs. Interferon (IFN)-γ and granzyme B
(GzmB) expression levels in BAL were signiﬁcantly increased by
day 7 pvi (Fig. 5a) and unbiased restimulation of lung cells with
PMA and ionomycin caused signiﬁcantly increased co-
production of IFN-γ and TNF-α by CD8+ T cells (Supplemen-
tary Figure 5a, b).
In order to assess the MuHV-4-speciﬁc CD8+ T cell response,
we took advantage of H-2b congenic BALB/B mice in which the
response against the well-established MuHV-4 immunodominant
H-2Db-restricted AGPHNDMEI (ORF6487–495) and H-2Kb-
restricted SVYGFTGV (ORF61524–531) epitopes could be mea-
sured35. We initially measured thoracic light emission after
MuHV-4-luc infection of BALB/B mice and observed similar
enhanced control of viral infection at day 7 pvi (Fig. 5b).
Strikingly, tetramer staining (Fig. 5c, d) and peptide restimulation
(Fig. 5e, f) revealed signiﬁcantly increased MuHV-4-speciﬁc
responses in the BALF and lung in BALB/B mice that were
initially exposed to S. mansoni eggs. Similar increased MuHV-4-
speciﬁc responses by day 7 pvi were observed when mice where
infected at day 29 or 43 after the initial i.p. injection of S. mansoni
eggs (Supplementary Figure 5c). Moreover, infection of BALB/B
mice with 1 × 104 PFU of MuHV-4 intranasally after their initial
infection with N. brasiliensis resulted in higher MuHV-4-speciﬁc
CD8+ T cell responses at day 7 pvi (Supplementary Figure 5d–h).
The results in Fig. 2e showed that S. mansoni eggs induced
expansion of TVM cells expressing a TCR able to recognize MHC
tetramers presenting the P. yoelii CSP280–288 peptide, absent from S.
mansoni Ags. In order to examine the development of effector Ag-
speciﬁc responses from CSP280–288-speciﬁc CD8+ T cells, we
infected BALB/c mice with a MuHV-4-luc-CSP virus expressing a
modiﬁed luciferase protein in which the H-2Kd-restricted CSP280-288
peptide was inserted in-frame (Supplementary Figure 5i). We
observed enhanced control of MuHV-4-luc-CSP infection in the
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Fig. 3 S. mansoni egg immunization ameliorates the control of MuHV-4 lung infection. BALB/c mice were injected with S. mansoni (Sm) eggs i.p. and
challenged i.v. (5,000 per injection) at day 14. At d22, MuHV-4-luc virus was administered i.n. (b–g, i 104 PFU per mouse; h 103, 104, or 105 PFU per mouse
in 30 μL PBS). a Experimental design. b Body weight change as percentage of initial weight. c Immunostaining of MuHV-4-infected cells in
representative lung sections of PBS- or Sm egg-treated mouse 7 days after MuHV-4-luc infection (day 7 pvi). Arrows indicate positive AEC signal. Dotted
line shows boundaries of an egg-centered (#) granuloma. d Combined dorsal and ventral measurements by live imaging of thoracic light emission following
D-luciferin injection. p s−1= photons per second. Representative photographs of bioluminescence signals of two mice per group are shown. e Lung titers at
day 7 pvi as determined by plaque assay. f Live imaging of light emission of superﬁcial cervical LN (scLN). g Splenic MuHV-4 DNA copy numbers at the
indicated time points. h Live imaging of thoracic light emission following MuHV-4-luc infection with three different infectious doses. i Live imaging of
thoracic light emission of lungs following MuHV-4-luc infection daily. Statistical signiﬁcance calculated using two-way analysis of variance (ANOVA) and
Sidak’s multiple-comparison test (**P < 0.01, ***P < 0.001, ****P < 0.0001). Data are representative of three independent experiments with ﬁve to ten mice
per group (mean ± s.e.m. in b, e–i)
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lung by day 7 pvi which was associated with an increased
response of effector CSP280–288-speciﬁc CD8+ T responses
(Fig. 5g), further supporting that TVM are conditioned by
exposure to helminths, which could explain the enhanced effector
responses against their cognate Ag.
To further investigate whether the enhanced Ag-speciﬁc CD8+
T cell response against MuHV-4 was responsible for the early
viral control observed in mice treated with S. mansoni eggs, mice
were treated with depleting antibodies against CD8 or CD4 one
day before MuHV-4 infection and then at days 1 and 4 pvi
(Fig. 5h). While depletion of CD4 did not inhibit the early control
of MuHV-4 infection observed in mice exposed to S. mansoni
eggs, the absence of CD8+ cells resulted in the total loss of such
early control. These results demonstrate a CD8-dependent
mechanism of enhanced control of viral infection and strongly
suggest that S. mansoni egg immunization rendered CD8+ T cell
responses more efﬁcient to clear MuHV-4 infection, indepen-
dently of CD4+ T cells.
Helminth exposure affects the gene-expression proﬁle of TVM.
To further investigate TVM phenotypic changes after exposure to
S. mansoni eggs, we compared gene-expression proﬁles between
PBS- or S. mansoni egg-treated TVM cells by RNA sequencing of
FACsorted TVM cells from the spleen (Supplementary Figure 6).
In total, we observed 29 differentially expressed (DE) genes (log2-
fold change > ± 0.5, P < 0.1) (Fig. 6a, b) and principal-component
analysis revealed clustering of PBS- or S. mansoni egg-treated
TVM cells (Fig. 6c). Among genes upregulated in S. mansoni
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Fig. 5 S. mansoni immunization augments speciﬁc antiviral CD8+ T cell responses to control lytic MuHV-4 infection. BALB/c or BALB/B mice were treated
with S. mansoni (Sm) eggs before being infected with MuHV-4-luc or MuHV-4-luc-CSP virus as outlined in Fig. 3a. a IFN-γ and GzmB concentrations in the
BALF after MuHV-4 infection determined by ELISA. b Live imaging of thoracic light emission after MuHV-4-luc infection of BALB/c or BALB/B mice prior
exposed to Sm eggs. Representative photographs of bioluminescence signals of two mice per group at day 7 pvi are shown. c Representative ﬂow contour
plots of DbORF6487–495 and KbORF61524–531 MuHV-4-speciﬁc tetramer stainings of lung cells at day 7 pvi. Numbers in gate indicate percentage of
tetramer-positive in CD8+ T cells. Mean ± s.e.m. are shown. d Number of MuHV-4-speciﬁc CD8+ T cells in the BALF and lung at day 7 pvi in BALB/B mice
based on ﬂow cytometric analysis in panel c. e Representative ﬂow contour plots of gated lung CD8+ T cells at day 7 pvi showing IFN-γ and TNF-α
intracellular stainings after ORF6487–495 or ORF61524–531 peptide restimulation. Numbers indicate percentage in each quadrant. f Percentage of IFN-γ and
TNF-α co-producing lung CD8+ T cells after ORF6487-495 or ORF61524-531 peptide restimulation and intracellular staining and ﬂow cytometric analysis as
detailed in e. g Live imaging of thoracic light emission after MuHV-4-luc-CSP infection of BALB/c mice and number of CSP280–288-speciﬁc CD8+ T cells in
the BALF and lung at day 7 pvi. h Anti-CD8 (YTS-169.4) or anti-CD4 (GK1.5) antibodies were injected at day -1, days 1 and 4 after MuHV-4 infection and
live imaging performed for thoracic light emission. Statistical signiﬁcance calculated using two-way analysis of variance (ANOVA) and Sidak’s multiple-
comparison test (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). Data are representative of two independent experiments with four to ﬁve mice per
group (mean ± s.e.m. in a, b, d–h)
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Fig. 6 Phenotypic changes in helminth-driven TVM cells. a–d Transcriptomics analysis of FACsorted spleen TVM treated as in Supplementary Figure 1a. a
Differentially expressed (DE) genes (P < 0.1) in red in volcano plot, and showing in the arrowheads the direction of upregulated expression. b Heatmap of
DE genes (P < 0.1, DE over 1.5-fold). Left margin shows hierarchical clustering and right annotation indicate gene symbols. c Principal-component analysis.
d Enrichment for selected hallmark gene-sets from the MSigDB by gene-set enrichment analysis with BubbleGUM. WT_AND_STAT5A−/−_STAT5B+/−
and WT_AND_STAT5A−/−_STAT5B+/− gene-sets were obtained from published data60. Key color indicates cell subset showing enrichment for the gene
set, and size of symbols and color intensity indicate signiﬁcance of enrichment (surface area proportional to absolute value of the normalized enrichment
score (NES); color intensity indicates the false-discovery rate (FDR)). Numbers in parentheses (above) indicate number of genes. NS not signiﬁcant. e EdU
incorporation in CXCR3hiCD49dlo TVM and CD49dhi TTM cells after Sm egg treatment as outlined in Supplementary Figure 1a. 1 × EdU, injection 4 h before
harvest; 4 × EdU, injection at days 18, 19, 20, and 21 after Sm egg i.p. injection. f Percentages of spleen TVM cells after Sm egg injection i.p. and IL-4 levels
after SEA restimulation of splenocytes at the indicated time points. g Percentage of spleen EdU+ TTM, TVM, or TN cells at the indicated time points after Sm
egg injection i.p. h Percentages of spleen TVM cells after IL-4c treatment in mice treated daily with FTY720. i Spleen CD8+ T cells were adoptively
transferred to congenic mice before injection of Sm eggs i.p. At 7 days, percentages of recipient or donor spleen TVM cells and IFN-γ-producing cells upon
restimulation in the spleen are shown in CD45.1.2+ recipient or CD45.1+ donor CD8+ T cells. Statistical signiﬁcance calculated using two-way analysis of
variance (ANOVA) and Sidak’s multiple-comparison test (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). Data are representative of two independent
experiments with three to ﬁve mice per group (mean ± s.e.m. in e, f and results from individual mouse are shown)
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egg-induced TVM cells, we observed some genes related to cyto-
toxicity functions (Gzma, Ctla2a, and Slc16a2), cytokine–cytokine
receptor interaction (Ccr2 and Ccr5) or IFN-I responses (Mx1)
(Fig. 6b). Further analysis of molecular signatures with Bub-
bleGUM36, a tool allowing gene-set enrichment analysis of
transcriptomic data, revealed that among the selected gene-sets
exposure to S. mansoni eggs induced a shift toward higher
expression of genes implicated in IFN-γ and IFN-I responses,
whereas reduced expression of genes involved in cholesterol
homeostasis (Fig. 6d). These data demonstrate that naive or S.
mansoni egg-induced TVM cells are phenotypically distinct and
further suggest that this memory T cell population has enhanced
capacity to initiate an antiviral response. Besides affecting their
transcriptomics phenotype, exposure to Sm eggs leads to TVM
expansion that could be due to IL-4 provoking their proliferation.
However, EdU incorporation in vivo after S. mansoni egg
immunization did not show overt proliferation in TVM cells, but
did so in TTM cells after a single EdU administration 4 h before
harvest (Fig. 6e). After a single injection of S. mansoni eggs, we
observed that levels of IL-4 response to SEA increased by day 4
after injection associated with the expansion of TVM cells (Fig. 6f).
However, only TTM cells showed signiﬁcant proliferation and
EdU incorporation over time after S. mansoni egg injection
remained low in TN and TVM (Fig. 6g). TVM expansion could also
result from a recruitment to the secondary lymphoid organs. To
address this hypothesis, we treated mice with the sphingosine-1
phosphate receptor signaling FTY720 to inhibit recruitment of
lymphocytes to the spleen. FTY720 treatment did not impair the
IL-4-dependent expansion of TVM in the spleen (Fig. 6h),
although the extent of the expansion was slightly affected by
inhibition of lymphocyte trafﬁcking. In addition, bulk CD8+ T
lymphocytes isolated from the spleen of naive mice were trans-
ferred to congenic naive BALB/c mice before immunization with
S. mansoni eggs. TVM expansion occurred irrespective of their
donor or recipient origin (Fig. 6i), further suggesting that
helminth-induced TVM expansion can occur in peripheral CD8+
T lymphocytes. Thus, these results suggest that the observed TVM
expansion likely result from the conversion from naive T cells
rather than proliferation or recruitment of TVM cells.
IL-4 signals in CD8+ T cells for early control of MuHV-4. Next,
we investigated the role of IL-4 responsiveness in the early control
mediated by CD8+ T cells after exposure to helminth Ags. We
ﬁrst used S. mansoni eggs to immunize WT or Il4ra−/− BALB/c
mice before subjecting them to intranasal MuHV-4 infection
(Fig. 7a). Il4ra−/− mice did not display the enhanced control of
MuHV-4 infection observed in WT mice, with Il4ra−/− mice
exposed to S. mansoni eggs displaying similar to higher thoracic
light signals. The lack of helminth-mediated early control of
MuHV-4 infection in Il4ra−/− mice was further associated with
the absence of increased CD8+ T cells in the lung at day 7 pvi
(Fig. 7b). These results suggest that IL-4 signaling during
helminth-elicited inﬂammation governs the early capacity of
BALB/c mice to generate effector CD8+ T cells and control viral
infection.
To examine whether the presence of S. mansoni eggs in the
pulmonary niche conditions the early control of MuHV-4
infection after exposure to helminth Ag, we injected S. mansoni
eggs to 8-week-old female BALB/c mice twice via the i.p. route at
2 weeks interval before MuHV-4-luc infection intranasally at day
22 (Supplementary Figure 7a). We found that the presence of S.
mansoni eggs in the lung was dispensable for the early control of
viral infection, with signiﬁcantly reduced light emission signals by
day 7 pvi. In addition, treatment with IL-4c at 2 days interval
before MuHV-4-luc infection intranasally at day 4 reduced the
levels of light emission reporting infection (Fig. 7c), which was
associated with enhanced effector CD8+ T cell responses in the
lung after MuHV-4 infection (Fig. 7d, e). These results further
suggest the role of IL-4-induced TVM cells in contributing to the
early effector CD8+ T cell responses against MuHV-4 infection.
The impact of IL-4 sensitivity of CD8+ T cells after
immunization with S. mansoni eggs on subsequent responses
against MuHV-4 infection was further investigated by co-transfer
of TVM-rich WT and TVM-poor Il4ra−/− puriﬁed CD8+ T cells
from PBS− or S. mansoni egg-treated mice cells in equivalent
numbers to congenic PBS− or S. mansoni egg-treated BALB/c
mice (Supplementary Figure 7b). Mice were then infected or not
with MuHV-4. The absolute numbers of donor WT and Il4ra−/−
CD8+ T cells localizing to the lung tended to increase at 7 day pvi
(Fig. 7f), and analysis of WT:Il4ra−/− donor cell ratios normal-
ized to uninfected mice demonstrated signiﬁcant enrichment of
donor WT CD8+ T cells compared to donor Il4ra−/− CD8+
T cells when the mice were initially treated with S. mansoni eggs
(Fig. 7g). Importantly, IL-4 signaling in CD8+ T cells resulted in
signiﬁcantly increased IFN-γ production after unbiased restimu-
lation of lung cells from S. mansoni egg-treated mice after
MuHV-4 infection, compared to the donor Il4ra−/− CD8+ T cell
compartment (Fig. 7h). These results demonstrated that IL-4
signaling in CD8+ T cells, probably through expansion of TVM
cells, contributes signiﬁcantly to condition effective antiviral CD8+
T cell responses and that IL-4Rα-dependent S. mansoni egg-
induced inﬂammation in the lung environment alone is not
sufﬁcient to signiﬁcantly enhance CD8+ T cell responses.
Nonetheless, it was unclear whether S. mansoni egg-induced
TVM cells could outcompete their naive counterparts. Thus, we
adoptively co-transferred TVM cells FACsorted from PBS− and S.
mansoni egg-treated mice cells in equivalent numbers to congenic
naive BALB/c mice. At day 7 after MuHV-4 infection, effector
T cells originating from transferred TVM cells could be detected in
lungs and BALF demonstrating the contribution of TVM cells to
the effector antiviral CD8 response (Fig. 7i). However, no
signiﬁcant differences could be observed between naive or Sm
egg-induced TVM compartments (Fig. 7j). Thus, although
phenotypically distinct to naive TVM cells, preliminary expansion
of TVM cells contributes to the early control of MuHV-4 infection.
Discussion
IL-4 and IFN-γ are usually considered antagonistic as hallmark
cytokines of type 2 and type 1 immunity, respectively. None-
theless, IL-4 can drive Eomes expression in CD8+ T cells and lead
to IFN-γ production23,37. We conﬁrm here that this intriguing
mechanism has functional consequences in vivo by providing
evidence that IL-4 induced by helminths can have under certain
circumstances, beneﬁcial bystander consequences on IFN-γ-
dependent antiviral effector responses through induction of
TVM expansion. Immunity against helminths could therefore have
evolved a safety mechanism through induction of highly
responding TVM cells to counterbalance negative effects of type 2
immunity on the development of effective antiviral responses.
Helminth infections are highly prevalent and have been shown
to modulate the immune system, sometimes leaving a long-lasting
imprint on the ability of the helminth-exposed hosts to respond
to heterologous Ags. Indeed, helminth infections can down-
modulate allergy or inﬂammatory bowel disease through various
mechanisms38, but have also been involved in modulating the
ability of the infected host to control virus infections. Several
groups have shown using C57BL/6 mice that exposure to H.
polygyrus or S. mansoni eggs enhanced reactivation from latency
of MuHV-4 through changes in the IL-4/IFN-γ balance10 and
also that intestine dwelling helminths could alter effector CD8+ T
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Fig. 7 Helminth-induced IL-4 conditions CD8+ T cells for early control of MuHV-4 infection. BALB/c mice were treated with S. mansoni eggs (Sm) (a, b) or
treated with IL-4c (c–e) before being infected with MuHV-4-luc virus. a Live imaging of combined dorsal and ventral thoracic light emission of WT or Il4ra−/−
mice after MuHV-4-luc infection. b Lung CD8+ T cell responses at day 7 pvi in WT or Il4ra−/− mice. c Live imaging of combined dorsal and ventral
thoracic light emission of mice subjected to the outlined treatments. d Lung CD8+ T cell responses and proportions of CD44hiCD62LloCD49dhi effector
CD8+ T cells at day 7 pvi in naive or IL-4c treated mice as in c. e Percentage of IFN-γ producing lung CD8+ T cells by intracellular staining after
restimulation with PMA and ionomycin at day 7 pvi. f–h Spleen CD8+ T cells were puriﬁed from WT CD45.1+ or Il4ra−/− CD45.2+ mice treated with PBS
or Sm eggs before co-transfer in PBS− or Sm egg-treated congenic CD45.1.2 WT recipient mice, followed by MuHV-4 infection as outlined in
Supplementary Figure 7b. f Donor cell numbers in lungs at 7 day pvi. g Ratio of donor cells in lungs at 7 day pvi normalized on uninfected control group
(PBS or Sm egg-treated uninfected mice for PBS or Sm egg-treated MuHV-4 infected mice). h Percentage of IFN-γ producing donor CD8+ T cells following
restimulation with PMA and ionomycin. i, j CD44hiCXCR3hiCD62LhiCD49dlo TVM cells were FACS-sorted from PBS-treated BALB/c CD45.1+ and Sm egg-
treated CD45.1.2+ mice, and equal numbers of cells were co-transferred into naive CD45.2+ recipients. One day after adoptive transfer, recipients were
infected with MuHV-4. i Total numbers of donor cells in spleen, lung and BALF at day 7 pvi. j Sm egg-TVM vs. PBS-TVM ratios at day 7 pvi. Statistical
signiﬁcance calculated using two-way analysis of variance (ANOVA) and Sidak’s multiple-comparison test (*P < 0.05, **P < 0.01, ***P < 0.001, ****P <
0.0001). Data are representative of two to three independent experiments with three to eight mice per group (mean ± s.e.m. in a-f, h). Each symbol
represents an individual mouse; small horizontal lines indicate the mean
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cell responses against a subsequent viral8 or protozoal infection39.
Nevertheless, these studies did not investigate how helminths
could affect bystander memory T cells such as the TVM com-
partment. Indeed, although TVM development can be highly
dependent on IL-4 direct signaling in CD8+ T cells22,25, little was
known on the ability of this cytokine to drive the expansion of
TVM in settings dominated by type 2 immunity such as exposure
to helminths. BALB/c mice provide an important opportunity to
investigate sensitivity to IL-4 of CD8+ T cells after egress from
the thymus as this strain show a particular sensitivity to IL-4 for
driving TVM development25. This aspect is of great importance as
disregarding IL-4-responsive TVM cells could thwart the full
understanding of the mechanism involved and how helminths
can affect bystander memory T cells such as TVM cells. Our data
reveal that exposure to helminths and derived products elicit Ag-
nonspeciﬁc expansion of the TVM compartment through direct
signaling of IL-4. Notably, we observed that such expansion was
associated with Eomes upregulation in TVM cells with no altera-
tion of T-bet expression levels, further characterizing these cells
as IL-4-induced TVM17. Such conditioning was observed in sev-
eral settings involving Th2-dominating responses such as
immunization with helminth Ags or infection with systemic or
intestinal helminths like S. mansoni, N. brasiliensis, or H. poly-
gyrus. These observations are important as they demonstrated
that helminths could actually condition bystander memory CD8+
T cells to respond more effectively to their cognate Ags to the
beneﬁt of the infected host.
Indeed, our ﬁndings revealed that helminths induced Ag-
nonspeciﬁc expansion of bystander TVM cells in secondary lym-
phoid organs via direct sensitivity to IL-4 that resulted in
increased Ag-speciﬁc effector CD8+ T cell responses in the lungs
of BALB/c mice to further enhance the control of MuHV-4 lytic
replication. These data are supported by previous reports showing
that IL-4Rα deﬁciency compromises the Ag-speciﬁc CD8+ T cell
response to lymphocytic choriomeningitis virus or inﬂuenza virus
infections whereas the ability of effector IL-4Rα-deﬁcient CD8+
T cells to kill was unaffected22,40. Thus, the inability of Il4ra−/−
mice for early control of MuHV-4 after S. mansoni egg exposure
lies in the ineffective development of TVM cells and absence of IL-
4 responsiveness of CD8+ T cells in these mice. Although IL-4
signaling in memory T cells was previously associated with
downregulation of NKG2D expression and impaired killing
capabilities28, we did not observe signiﬁcant modulation of
NKG2D mRNA expression levels after S. mansoni egg treatment
in our experimental settings and we observed increased CD8+
antiviral effector responses in the lung. Our transcriptomics data
rather indicated that S. mansoni egg-induced TVM were pheno-
typically distinct from naive TVM cells with increased IFN-γ and
IFN-α gene signatures. Nonetheless, their ability to react against
their cognate Ag and migrate to the infected lungs was not sig-
niﬁcantly different to naive TVM in a competitive adoptive
transfer in naive congenic mice. These observations suggest that
both expansion of the TVM compartment after exposure to hel-
minths and alterations of their phenotype can explain the early
response to MuHV-4 Ags and subsequent early control. In
addition, the low-proliferation levels in the TVM population after
exposure to S. mansoni eggs together with the observation that
FTY720 did not inhibit TVM expansion in the spleen after IL-4c
treatment and TVM expansion in adoptively transferred congenic
CD8+ T lymphocytes suggested that the expansion is likely due to
conversion from naive CD44lo T cells while independent of
proliferation or recruitment to the spleen. As a consequence,
expansion of the TVM pool is likely associated with an enrichment
of the TCR repertoire in this bystander memory population
rather than the proliferation of pre-existing TVM cells, a phe-
nomenon that could signiﬁcantly augment the probability of
effective Ag priming together with the ability of TVM cells to
outcompete their naive CD44lo T cell counterpart30.
Whether helminth-induced bystander TVM cells is also asso-
ciated with MuHV-4-speciﬁc true memory CD8+ T cells after
lytic infection remains unknown, but the establishment of effec-
tive memory is rather suggested by a previous report demon-
strating that establishment of effective memory against malaria
requires IL-4Rα on CD8+ T cells41. This could have important
implication for improved vaccination strategies and should fur-
ther encourage investigators to unravel how TVM cells can be
effectively expanded in multiple settings with various types of
Ags. Latency during gammaherpesvirus infections such as Kaposi
Sarcoma-associated herpesvirus or Epstein–Barr virus, is mainly
responsible for malignancies such as lymphomas in human42,43, a
phase during which virus-infected cells evade CD8+ T cell
recognition44. However, reactivation events of lytic replication
occur and are believed to maintain sufﬁcient levels of infection in
the host as well as for transmission33. Thus, an effective
memory T cell response to control these reactivation events is
important. Understanding how helminth-driven expansion of
TVM cells impact on long term virus-speciﬁc memory is therefore
essential.
In conclusion, we provide evidence that helminth-driven type 2
immune responses drives TVM expansion through IL-4 which
could in turn positively condition effector Ag-speciﬁc CD8+
T cells responses and signiﬁcantly enhance the control of viral
infection such as lytic gammaherpesvirus infections.
Methods
Cells. Baby Hamster Kidney (BHK)-21 [C13] ﬁbroblasts (ATCC CCL-10) were
purchased from ATCC (Manassas, VA, USA) and cultured in Dulbecco’s Modiﬁed
Eagle Medium (DMEM, Sigma-Aldrich) supplemented with 2 mM glutamine, 100
Uml−1 penicillin, 100 mgml−1 streptomycin and 10% fetal calf serum (FCS) at 37
°C under 5% of CO2. Cells were free of mycoplasma contamination (PlasmoTest
Mycoplasma Detection Kit, Invivogen).
Viruses. The MHV-68 strain of Murid Herpesvirus-4 (MuHV-4) expressing
luciferase under the control of the M3 promoter (MuHV-4-Luc)45 was propagated
on BHK-21 cells. Cells and supernatant were harvested at about 4 days post-
infection (~85% of lysis) and debris were removed by low-speed centrifugation
(1000 × g, 10 min, 4 °C). Virions present in the supernatant were harvested by
ultracentrifugation (100,000 × g, 2 h at 4 °C) and puriﬁed through a 30% weight
volume−1 sucrose cushion (100,000 × g, 2 h at 4 °C), washed in PBS before being
stored in PBS at −80 °C. Viral titers were determined by plaque assay on BHK-21
cells46. Brieﬂy, BHK-21 cells monolayers were incubated with 10-fold dilution of
viral stock at 37 °C, 5% CO2 for 3 h. Inoculum was then replaced by semisolid
medium containing 0.6% carboxymethylcellulose. Cells were further incubated for
4 days then ﬁxed in 4% paraformaldehyde and stained for plaques counting.
To assess antigen-speciﬁc CD8+ T cells responses in BALB/c mice, we modiﬁed
the MuHV-4-luc virus to insert the H-2Kd-restricted SYVPSAEQI peptide of the
circumsporozoite protein of P. yoelii (CSP280–288) in frame of the luciferase sequence
to generate a MuHV-4-luc-CSP virus strain. First, primers PL451-HindIII-CSP-
STOP-HindIII-Fwd (5′-gtcgacggtatcgataagcttagaggaccagggagagcatttgttacaatatcttatgt
cccaagcgcggaacaaatataaaagcttgatatcgaattccga-3′) and PL451-HindIII-STOP-CSP-Hin
dIII-Rev (5′-tcggaattcgatatcaagcttttatatttgttccgcgcttgggacataagatattgtaacaaatgctctccct
ggtcctctaagcttatcgataccgtcgac-3′) were annealed and inserted in the HindIII site of
the pL451 plasmid vector (http://redrecombineering.ncifcrf.gov/) using inFusion HD
kit (Promega) to generate pL451-CSP. Plasmid pL451 contains an FRT-ﬂanked
expression cassette of the kanamycin/neomycin resistance gene (KanaR) as selection
marker in Escherichia coli47,48. Then, the CSP sequence was inserted in frame to the
carboxy-terminus of the luciferase coding sequence of the MuHV-4-luc BAC clone
using an amplicon generated by PCR with primers MuHV-Luc-CSP-Fwd (5′-
agatccgcgagattctcattaaggccaagaagggcggcaagatcgccgtgagaggaccagggagagcatt-3′) and
MuHV-Luc-CSP-Rev (5′-atgtatctatcatgtctgctcgaagcggccggccgccccgactctagaaatattat
gtacctgactgat-3′) and pL451-CSP as template (Supplementary Figure 5h). Phage
λ-mediated recombineering in SW105 bacteria (http://redrecombineering.ncifcrf.
gov/) followed by arabinose-induced FLP expression for excision of FRT-ﬂanked
sequence were used49. The generated MuHV-4-luc-CSP BAC construct was veriﬁed
by an endonuclease restriction and Southern blotting approach and sequencing of
the recombination genomic region. The loxP-ﬂanked BAC cassette was removed by
virus growth in NIH 3T3-Cre cells to produce MuHV-4-luc-CSP BAC− virus50.
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Parasites. S. mansoni-exposed Swiss-Webster mice and snails were provided by
the Schistosome Research Reagent Resource Center for distribution by BEI
Resources, NIAID, NIH: Schistosoma mansoni, Strain NMRI exposed Biomphalaria
glabrata, Strain NMRI (NR-21962), S. mansoni, Strain NMRI exposed Swiss-
Webster mice (NR-21963). S. mansoni cercariae were collected from S. mansoni
exposed B. glabrata, and used for natural infection. S. mansoni eggs used for egg
immunization, were collected from S. mansoni-exposed Swiss-Webster mouse liver
and stored in PBS at −80 °C, as previously described with minor modiﬁcations27.
Brieﬂy, livers were cut into small pieces with scissors and incubated individually in
50-mL tubes overnight in 20 mL of PBS containing 100 µg ml−1 collagenase IV
(Sigma-Aldrich). The homogenates were then slowly poured onto strainers of
decreasing mesh sizes (425 µm/180 µm/106 µm and 45 µm). Eggs present on top of
the 45 µm strainer were collected with PBS and centrifuged for 5 min at 400 × g at
RT. Pellets were suspended in 10 mL PBS and layered onto 20% Percoll in 0.25 M
sucrose (Sigma-Aldrich) and centrifuged at 800 × g for 10 min at RT. Pellets were
then washed in PBS containing 1 mM EGTA and 1 mM EDTA before layered onto
25% Percoll in 0.25 M sucrose and centrifuged at 800 × g for 10 min at RT. Pellets
were further washed in PBS, counted and resuspended at 50,000 eggs ml−1 and
stored in PBS at −80 °C. Soluble Egg Antigen (SEA) from S. mansoni were pre-
pared as previously described51. Eggs were suspended in PBS at a concentration of
100,000 eggs ml−1 and homogenized with a Potter-Elvehjem hand-held homo-
genizer and centrifuged (2000 × g, 20 min at 4 °C). The supernatant was ultra-
centrifuged (100,000 × g, 90 min at 4 °C) and the ﬁnal supernatant was ﬁlter-
sterilized before being stored at −80 °C. Protein concentration was determined by
BCA assay (Thermoﬁsher, 23225). Recombinant ω-1 protein was generated in
Nicotiana benthamiana and puriﬁed from the leaf extracellular space using POROS
50 cation resin (Life Technologies)52.
N. brasiliensis was maintained in male Sprague–Dawley rats as described53. N.
brasiliensis L3 larvae were isolated from day 6 to 9 fecal cultures through a
Baermann apparatus and used for subcutaneous infection.
H. polygyrus was maintained in male CBA mice as described54. H. polygyrus L3
larvae were isolated from fecal cultures and stored in distilled water at 4 °C.
Animals. The experiments, maintenance and care of mice and rats complied with
the guidelines of the European Convention for the Protection of Vertebrate Ani-
mals used for Experimental and other Scientiﬁc Purposes (CETS n° 123). The
protocol was approved by the Committee on the Ethics of Animal Experiments of
the University of Liège, Belgium (Permit nos. 1357, 1713, and 1849). All efforts
were made to minimize suffering. Female BALB/cOlaHsd wild-type mice,
6–8 weeks old and Sprague–Dawley male rats were purchased from Envigo
(Venray, Netherlands). Female BALB/B mice (C.B10-H2b/LilMcdJ), that are BALB/
c congenic for the C57BL/10-derived H-2b region, were maintained at the Scientiﬁc
Institute of Public Health, Belgium and transferred to the University of Liege,
Department of Infectious Diseases for experiments. BALB/c Cd45.1+ genitor mice
were generously provided by Prof. U. Eriksson (Center for Molecular Cardiology,
University of Zurich). BALB/c Cd45.1+Cd45.2+ were obtained by crossing Cd45.1+
BALB/c mice with wild-type BALBc/OlaHsd (Cd45.2+). Il4ra−/− BALB/c mice
were bred at the University of Liège, Department of Infectious Diseases. Six- to
eight-week-old female littermates were randomly assigned to experimental groups.
During experiences, four to ﬁve female mice were cohoused per cage, food and
water was provided ad libitum. All the animals were bred and/or housed in the
University of Liège, Department of Infectious Diseases.
Mixed bone-marrow chimeric mice models. Mixed bone-marrow chimeric mice
were produced by exposing CD45.1+CD45.2+ BALB/c mice to a whole body lethal
irradiation protocol (Gammacell 40 Exactor, 4.5 Gy, two expositions at 3-h interval).
The next day, mice were reconstituted by intravenous injection of 4.5 × 106 BM cells
isolated from femurs and tibias of donor CD45.1+WT and CD45.2+ Il4ra−/− mice
and mixed at a 1:1 ratio. From 1 week before to 3 weeks after irradiation, mice were
given broad-spectrum antibiotherapy (0.27 g trimethoprimum and 1.33 g sulfa-
diazinum per liter of drinking water, Emdotrim 10%, Ecuphar). Mice were left
untreated for 8 weeks to allow complete reconstitution and chimerism of the
different blood leukocytes populations was then conﬁrmed by ﬂow cytometry.
Helminth infections and immunization with helminth Ags. For natural infection
with S. mansoni, mice were anesthetized by intraperitoneal injection of 16 mg kg−1
of xylazine and 100 mg kg−1 of ketamine and infected by percutaneous exposure to
35 cercariae during 30 min. Treatment with S. mansoni eggs consisted of an
intraperitoneal immunization on day 0 (5000 eggs per mouse) followed by one
intravenous injection of 5000 eggs on day 14. In some experiments, mice received
S. mansoni eggs (5000 eggs per mouse), SEA (60 μg per mouse) or recombinant ω-1
(10 μg per mouse) intraperitoneally at 2 weeks interval.
Mice anesthetized by isoﬂurane inhalation were infected with N. brasiliensis by
subcutaneous injection of 500 × L3 larvae. In some experiments, mice were treated
with ivermectin (10 mg L−1 of drinking water, Noromectin, Norbrook) from day
14 to 21 after N. brasiliensis infection. Mice were infected with H. polygyrus by
oral gavage (200 × L3).
IL-4 complex treatment. Mice received 2 intraperitoneal injections of IL-4c: 5 µg
of recombinant IL-4 (BioLegend, carrier-free, Cat # 574306) and 25 µg of anti-IL-4
antibody (BioLegend, clone 11B11, LEAF puriﬁed, Cat # 504108) per mouse at days
0 and 2.
FTY720 treatment. In order to block lymphocyte trafﬁcking, mice received daily i.
p. administration of 1 mg kg−1 of FTY720 (Sigma-Aldrich) dissolved in 100 ml of
sterile water as described elsewhere55.
Peptide-MHC class I tetramer enrichment. Enrichment of Ag-speciﬁc CD8+
T cells was performed using an established protocol22. Combined spleen and
lymph nodes were digested with collagenase D. Cells were then labeled with APC-
conjugated H-2Kd-CSP280–288 tetramer (SYVPSAEQI, NIH Tetramer Core Facil-
ity) for 30 min at room temperature, followed by magnetic enrichment over LS
columns using anti-APC microbeads (Miltenyi biotec). Enriched samples and
unbound fractions were stained with surface antibodies, and Polybead polystyrene
microspheres (Polyscience) were used for calculating cell number.
Viral infection and quantiﬁcation. Mice were anesthetized with isoﬂurane and
104 PFU (103 or 105 PFU for some experiments) of MuHV-4-Luc or MuHV-4-
Luc-CSP was administered intranasally in 30 µl of PBS. Light emission was then
monitored by in vivo bioluminescence imaging using a IVIS Spectrum In Vivo
Imaging System (Perkin Elmer) after D-luciferin intraperitoneal injection (75 mg
kg−1, Perkin Elmer). Living Image v4.1 software (Perkin Elmer) was used to obtain
the total ﬂux (photons s−1) using a ﬁxed-sized region of interest or average radi-
ance (photons s−1 cm−2 steradiants−1).
Infectious virus in lungs was quantiﬁed after homogenization using glass Potter-
Elvehjem hand-held homogenizers after freezing (−80 °C) in 6 ml complete
medium prior to plaque assay46.
Viral genome loads were measured using a Taqman-based real-time PCR
reaction (CFX)56. DNA was extracted from spleens using Wizard genomic DNA
puriﬁcation kit (Promega) and 100 ng per sample was used in iQ supermix
(Biorad) to amplify a MuHV-4-speciﬁc sequence (genomic co-ordinates
43,015–43,138, NC_001826.2): gene ORF25 with primers ORF25fwd, 5′-
atggtatagccgcctttgtg-3′ and ORF25rev 5′-acaagtggatgaagggttgc-3′ and probe 5′-6-
carboxyﬂuorescein [FAM]-caaccactggatcagcataaaacttatgaa-black hole quencher
[BHQ1]-3′. Cellular DNA was quantiﬁed in parallel by amplifying the interstitial
retinoid binding protein (IRBP) gene sequence using iQ SYBR Green supermix
(Biorad) and IRBPfwd 5′-atccctatgtcatctcctacytg-3′ and IRBPrev 5′-
ccrctgccttcccatgtytg-3′ primers. Standard curves were obtained using pGEMT-easy
(Promega) plasmid templates in which MuHV-4 ORF25 or mouse IRBP sequences
were cloned, respectively. Ampliﬁed products were distinguished from paired
primers by melting curve analysis and the correct sizes of the ampliﬁed products
conﬁrmed by electrophoresis and staining with ethidium bromide.
Histology and immunohistochemistry. Lungs were collected from PBS-perfused
animals and immediately ﬁxed in 10% neutral buffered formalin. Tissues were
embedded and sectioned, and sections were stained with hematoxylin and eosin.
Immunochemistry was performed using EnVision Detection Systems (DAKO)
with anti-MHV-68 rabbit polyserum or naive rabbit serum as primary antibodies.
Antigen-speciﬁc antibody titers. Nunc Maxisorp ELISA plates (Nalgene Nunc)
were coated overnight at 4 °C with MuHV-4 virions (106 PFUml−1 of carbonate
buffer pH 9.5 containing 0.1% Triton X-100), or SEA (10 µg mL−1 in carbonate
buffer) before being incubated for 1 h in wash/blocking buffer (0.1% Tween-20 and
3% BSA in PBS) at RT. Plates were then incubated with mouse sera (serial dilu-
tions) in wash/blocking buffer for 2 h at RT. Detection was performed using
alkaline phosphatase-conjugated anti-mouse IgG1 or IgG2a (BD Biosciences) in
wash/blocking buffer for 1 h at RT. Chromogenic reaction was performed using p-
Nitrophenylphosphate (Sigma) and stopped in NaOH 1M before absorbance was
read at 405 nm using a iMark ELISA plate reader (Biorad).
BAL cytokines quantiﬁcation. After euthanasia, airways were ﬂushed twice with 1
ml of ice cold PBS containing protease inhibitors (cOmplete, Roche) via cathe-
terization of the trachea. Quantiﬁcation of IL-4, IFN-γ and granzyme B was per-
formed using speciﬁc Ready-SET-Go kits (eBioscience, Cat # 88-8022-88, Cat # 88-
7314-88, and Cat # 88-7044-88) following the manufacturer’s instructions.
Tissue processing and cell preparation. Airways were ﬂushed twice with 1 ml of
ice cold PBS, cells were harvested by centrifugation of the BAL ﬂuid. After section
of the vena cava, lungs were perfused with 5 ml of ice-cold PBS through the right
ventricle. Lung were dissociated with the gentleMACS dissociator (Miltenyi Biotec)
in C-tubes (Miltenyi Biotec), incubated in HBSS (Gibco), 5% FCS, 1 mgml−1 of
collagenase D (Roche), and 0.1 mgml−1 of DNase I (Roche) for 30 min at 37 °C
under agitation and further dissociated with the gentleMACS dissociator. The
resulting suspension was washed in cold PBS with 2 mM EDTA and ﬁltered on a
100 µm cell strainer (Falcon). Spleen and cranial and caudal mediastinal lymph
nodes were disrupted using scissors and a sterile syringe plunger and ﬁltered
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through a 70 µm ﬁlter. Erythrocytes were lysed in red cell lysis solution (155 mM
NH4CL, 0.12 mM EDTA, 10 mM KHCO3) and counted in a Neubauer cytometer
chamber with trypan blue 0.4% dye for exclusion of dead cells.
Flow cytometry and cell sorting. Incubations were performed in FACS buffer
(PBS containing 0.5% BSA and 0.1% NaN3) at 4 °C. Cells were ﬁrst incubated with
anti-mouse CD16/32 antibody (clone 93, 1 µg ml−1, BioLegend, Cat # 101302)
before ﬂuorochrome-conjugated antibodies against surface antigens were added
and incubated during 20 min at 4 °C. Various panels were used including anti-
bodies to CD3e (clone 145-2C11, 0.4 µg ml−1, APC, Cat# 17-01031-81), CD19
(MB19-1, 0.4 µg ml−1, APC, Cat # 17-0191-82), CD4 (RM4-5, 0.4 µg ml−1, PerCP-
Cy5.5, Cat # 45-0042-82), CD44 (IM7, 0.4 µg ml−1, PE, Cat # 12-0441-82), CD49d
(R1-2, 2.5 µg ml−1, biotinylated, Cat # 13-0492), CD62L (MEL-14, 0.8 µg ml−1,
eFluor 450, Cat # 48-0621-82), MHC class II (M5/114.15.2, 0.1 µg ml−1, PE-Cy7,
Cat # 25-5321-82 or eFluor 450, Cat # 48-5321-82), Gr-1 (RB6-8C5, 1 µg ml−1,
FITC, Cat # 11-5931-82), CD11c (N418, 0.8 µg ml−1, PerCP-Cy5.5, Cat # 45-0114-
80 or Alexa Fluor 700, Cat # 56-0114-82), Ly6C (HK1.4, 0.2 µg ml−1, PE-Cy7, Cat
# 25-5932-80), CD11b (M1/70, 0.4 µg ml−1, APC-eFluor 780, Cat # 47-0112-80) all
from eBioscience/ThermoFisher Scientiﬁc; antibodies to CD3 molecular complexe
(17A2, 0.4 µg ml−1, v450, Cat # 561389), CD19 (1D3, 0.4 µg ml−1, APC-Cy7, Cat #
557655), CD8a (53-6.7, 1 µg ml−1, FITC, Cat # 553031), CD183 (CXCR3-173, 2 µg
ml−1, PE, Cat # 562152), KLRG1 (2F1, 0.4 µg ml−1, PE, Cat # 561621), CD127 (SB/
199, 4 µg ml−1, BV786, Cat # 563748), Siglec-F (E50-2440, 0.4 µg ml−1, PE, Cat #
552126 or PE-CF594, Cat # 562757), CD45.1 (A20, 2 µg ml−1, APC, Cat # 558701),
CD45.2 (104, 0.4 µg ml−1, v500, Cat # 562129) all from BD Biosciences and
antibody to CD44 (IM7, 0.4 µg ml−1, PE-Cy7, Cat # 103030), and CD45.1 (A20,
0.8 µg ml−1, BV421, Cat # 110732) from BioLegend. Biotinylated antibodies were
detected using BV650-conjugated streptavidin (0.2 µg ml−1, BD Biosciences, Cat #
563855). Dead cells were stained using Fixable Viability Stain 510 (0.4 µg ml−1, BD
Bioscience, Cat # 564406) or Fixable Viability Dye eFluor 780 (1000× dilution,
eBioscience, Cat # 65-0865-14). In experiments in which intranuclear staining for
transcription factors was needed, cells were ﬁxed and permeabilized using Foxp3/
Transcription factor staining buffer set (eBioscience, Cat # 00-5523-00) following
manufaturer’s instruction and incubated 30 min at 4 °C with antibody against
either T-bet (O4-46, 100× dilution, PE, BD Biosciences, Cat # 561268) or Eomes
(Dan11mag, 2 µg ml−1, PE, eBioscience, Cat # 12-4875-82) diluted in permeabili-
zation buffer. Samples were analyzed on a BD LSR Fortessa X-20 ﬂow cytometer,
cell sorting was performed on a FACS Aria IIIu (BD biosciences).
In vivo EdU incorporation. To assess the proliferation of virtual memory CD8+ T
lymphocytes upon helminth exposure, S. mansoni eggs exposed mice were injected
ip with EdU (500 µg per mouse in PBS, ThermoFisher Scientiﬁc) 4 h before end-
point (1×) or daily for 4 days before endpoint (4×). Mice were euthanized and
spleen were processed as described above. Surface staining was performed with
exception of PE-conjugated antibodies. After dead cells staining, cells were ﬁxed for
15 min at room temperature in Click-It Fixative (ThermoFisher Scientiﬁc), washed
with PBS/1%BSA and incubated 15 min at RT in Click-It Saponine-Based Per-
meabilization Buffer (ThermoFisher Scientiﬁc). Cells were then resuspended in
freshly prepared EdU staining cocktail [10 µM Paciﬁc Blue-azide, 1 mM CuSO4, 10
mM sodium ascorbate with 1 mM THPTA (tris((1-hydroxy-propyl-1H-1,2,3-tria-
zol-4-yl)methyl)amine) and 10 mM amino-guanidine in PBS] and incubated 2 h at
RT57. Cells were washed with Click-It Saponine-Based Permeabilization Buffer and
incubated with PE-conjugated antibodies for 20 min at 4 °C. Samples were analyzed
on a BD LSR Fortessa X-20 ﬂow cytometer (BD Biosciences).
MHC-tetramer stainings. Lung and BAL cells were processed as described above
from BALB/B mice (H-2b congenic BALB/c). Cells were incubated with BV421-
conjugated tetramers H-2Db-ORF6487–495 (AGPHNDMEI, 90 nM) or H-2Kb-
ORF61521–531 (TSINFVKI, 45 nM), or APC-conjugated H-2Kd-CSP280–288 (80
nM) (NIH Tetramer Core Facility), respectively, for 30 min at RT before further
staining. Samples were analyzed on a BD LSR Fortessa X-20 ﬂow cytometer (BD
Biosciences).
Ex vivo restimulation and cytokine production. Cytokine production upon res-
timulation was assessed by intracellular cytokine staining (ICCS) and ﬂow cyto-
metry or by ELISA on culture supernatants. For ICCS, cells were cultured at 37 °C,
5% CO2 in IMDM complemented with 2 mM glutamine, 100 U penicillin ml−1, 100
mg streptomycin ml−1 and 10% FCS for 4 h in presence of brefeldin A (10 µg mL
−1, eBioscience, Cat # 00-4506-51), monensin (2 µM, eBioscience, Cat # 00-4505-
51), and restimulating agent. For unbiased restimulation, cells were incubated with
phorbol 12-myristate 13-acetate (PMA, 20 ng mL−1, Sigma-Adlrich, Cat # P8139)
and ionomycin (1 µg mL−1, Sigma-Adlrich, Cat # I0634). For antigen-speciﬁc
restimulation, cells were incubated with H-2b-restricted MuHV-4 ORF6487–495
(AGPHNDMEI) and ORF61521-531 (TSINFVKI) peptides (1 μM). Following sur-
face and viability stainings, cells were ﬁxed in 2% paraformaldehyde overnight and
washed with Permeabilization Buffer (eBioscience) before being incubated with
antibodies against IFN-γ (clone XMG1.2, 2 µg ml−1, PE, BioLegend, Cat # 505808)
and TNF-α (clone MP6-XT22, 0.67 µg ml−1, BV711, BD Biosciences, Cat #
563944) in Permeabilization Buffer for 20 min at 4 °C. For ELISA, cells were
cultured at 37 °C, 5% CO2 in IMDM complemented with 2 mM glutamine, 100 U
penicillin ml−1, 100 mg streptomycin ml−1 and 10% FCS for 72 h with SEA
(20 µg mL−1). Supernatant were collected and conserved at −20 °C. Quantiﬁcation
of cytokines IL-4 and IFN-γ was performed using speciﬁc ELISA (Ready-SET-Go,
eBioscience) following manufacturer’s instructions.
In vivo CD8+ or CD4+ cells depletion. For depletion experiments, mice were
injected intraperitoneally with anti-CD8 (clone YTS-169.4, 200 μg per injection) or
anti-CD4 (clone GK1.5, 200 μg per injection) both obtained from BioXCell at day
−1, 1 and 4 after MuHV-4-Luc infection. Depletion was conﬁrmed by ﬂow
cytometry analysis of blood cells on day 6.
T cell enrichment and competitive adoptive transfer. Spleen single-cell sus-
pensions were obtained by forcing through a 70 μm cell strainer (Falcon) before cell
counts determined. CD8+ T cells were then enriched using negative magnetic
isolation (Miltenyi Biotec) and used either for adoptive transfer of bulk CD8+
T cells or for further TVM puriﬁcation: enriched CD8+ T cells were then FACsorted
to isolate CD44hiCXCR3hiCD62LhiCD49dlo TVM cells to high purity (>97%) before
further analysis or adoptive transfer. Competitive adoptive transfer of naive and Sm
egg-induced TVM cells consisted in the intravenous administration into WT naive
BALB/c congenic recipients of equal numbers (4 × 106 cells total) of naive and Sm
egg-induced TVM cells. For competitive transfer of WT and Il4ra−/− bulk CD8+
T cells, equal number (4 × 106 cells total) of WT and Il4ra−/− enriched CD8+
T cells from naïve or Sm egg-treated BALB/c mice were intravenously administered
respectively into naive or Sm egg-treated WT BALB/c congenic recipients.
RNA sequencing. TVM cells were extracted as described in the previous section
before RNA extraction with on-column DNase treatment (RNeasy Plus mini kit,
Qiagen). Integrity of extracted RNAs was controlled on a 2100 Agilent Bioanalyzer
and samples with a RNA integrity number > 9 were processed for RNA sequencing.
Libraries were prepared from 0.5 μg of RNA of three independent replicates per
group, using the Illumina TruSeq Stranded mRNA library preparation kit. Libraries
were then sequenced and bioinformatics analysis was performed. Approximately
30 million 75-base single-end reads were generated per sample. Quality control
checks on raw sequencing data for each sample were performed using FastQC
(Babraham Bioinformatics). Reads were mapped to the mouse reference genome
(mm10) using STAR (version 3.4.0)58. Subsequently the analysis was performed
with R Bioconductor packages:59 Rsamtools (version 1.18.3) and GenomicAlign-
ments (version 1.2.2) were used to count the reads by exons, and gene count
datasets were then analyzed to determine DE genes (DEGs) using DESeq2 (version
1.16.1). A gene was determined to be a DEG by passing FDR < 0.1 and log 2-fold
change ≥ ±0.5.
Statistical analysis. Statistical evaluation of different groups was performed either
by analysis of variance (ANOVA) followed by the Dunnett or Sidak multiple-
comparison test or by nonparametric Mann–Whitney test, as indicated. A P value
< 0.05 was considered signiﬁcant. Statistical analyses were performed using Prism
v6 (Graphpad, La Jolla, CA).
Data availability
Sequence data that support the ﬁndings of this study have been deposited in the Gene
Expression Omnibus (GEO) repository with the primary GSE110971 accession code. All
other data are available from the authors upon request.
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